1. Home
  2. COGT vs HLMN Comparison

COGT vs HLMN Comparison

Compare COGT & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • HLMN
  • Stock Information
  • Founded
  • COGT 2014
  • HLMN 1964
  • Country
  • COGT United States
  • HLMN United States
  • Employees
  • COGT N/A
  • HLMN N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • HLMN Industrial Machinery/Components
  • Sector
  • COGT Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • COGT 2.3B
  • HLMN 1.9B
  • IPO Year
  • COGT 2018
  • HLMN N/A
  • Fundamental
  • Price
  • COGT $36.63
  • HLMN $8.47
  • Analyst Decision
  • COGT Buy
  • HLMN Buy
  • Analyst Count
  • COGT 13
  • HLMN 6
  • Target Price
  • COGT $28.08
  • HLMN $12.20
  • AVG Volume (30 Days)
  • COGT 4.8M
  • HLMN 1.0M
  • Earning Date
  • COGT 11-03-2025
  • HLMN 11-04-2025
  • Dividend Yield
  • COGT N/A
  • HLMN N/A
  • EPS Growth
  • COGT N/A
  • HLMN 388.43
  • EPS
  • COGT N/A
  • HLMN 0.19
  • Revenue
  • COGT N/A
  • HLMN $1,536,647,000.00
  • Revenue This Year
  • COGT N/A
  • HLMN $8.11
  • Revenue Next Year
  • COGT N/A
  • HLMN $7.85
  • P/E Ratio
  • COGT N/A
  • HLMN $44.38
  • Revenue Growth
  • COGT N/A
  • HLMN 4.47
  • 52 Week Low
  • COGT $3.72
  • HLMN $6.55
  • 52 Week High
  • COGT $37.08
  • HLMN $11.64
  • Technical
  • Relative Strength Index (RSI)
  • COGT 83.97
  • HLMN 39.68
  • Support Level
  • COGT $32.85
  • HLMN $7.95
  • Resistance Level
  • COGT $36.29
  • HLMN $8.93
  • Average True Range (ATR)
  • COGT 2.62
  • HLMN 0.30
  • MACD
  • COGT 1.10
  • HLMN -0.06
  • Stochastic Oscillator
  • COGT 98.45
  • HLMN 36.33

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

Share on Social Networks: